BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bellingrath JS, McClements ME, Kaukonen M, Fischer MD, MacLaren RE. In Silico Analysis of Pathogenic CRB1 Single Nucleotide Variants and Their Amenability to Base Editing as a Potential Lead for Therapeutic Intervention. Genes (Basel) 2021;12:1908. [PMID: 34946856 DOI: 10.3390/genes12121908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kaukonen M, McClements ME, MacLaren RE. CRISPR DNA Base Editing Strategies for Treating Retinitis Pigmentosa Caused by Mutations in Rhodopsin. Genes (Basel) 2022;13:1327. [PMID: 35893064 DOI: 10.3390/genes13081327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bellingrath JS, McClements ME, Shanks M, Clouston P, Fischer MD, MacLaren RE. Envisioning the development of a CRISPR-Cas mediated base editing strategy for a patient with a novel pathogenic CRB1 single nucleotide variant. Ophthalmic Genet 2022;:1-10. [PMID: 35538629 DOI: 10.1080/13816810.2022.2073599] [Reference Citation Analysis]